Paul L. Juneau
Paul L. Juneau publishes mostly in Oncology, Economics and Econometrics and Rheumatology, on topics such as Parkinson's Disease Mechanisms and Treatments, Diabetes Treatment and Management and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #1,888,092 of 7,710,434 ranked researchers
- Rank in United States
- #577,250 of 1,627,098
- Works
- 91
- Citations
- 3.3k
- Citations per work
- 35.8
What does Paul L. Juneau research?
Paul L. Juneau's work is mostly in Medicine (29%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5965.0%
- Health Sciences2628.7%
- Medicine2628.7%
- Social Sciences66.3%
- 1Oncology8% of their works
- 2Economics and Econometrics6% of their works
- 3Rheumatology6% of their works
- 4Endocrinology, Diabetes and Metabolism5% of their works
- 5Physiology5% of their works
- 6Neurology5% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Neuroscience and Neuropharmacology Research
- Economic and Financial Impacts of Cancer
- Biosimilars and Bioanalytical Methods
- Colorectal Cancer Treatments and Studies
- Alzheimer's disease research and treatments
Which keywords describe Paul L. Juneau's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, a-Synuclein, Parkinson's Disease, Cardiovascular Outcomes, Cost-effectiveness Analysis, Quality of Life and Type 2 Diabetes.
- Tau Pathology
- Immunogenicity
- Biosimilars
- Synaptic Plasticity
- Financial Toxicity
- Type 2 Diabetes
- Cost-effectiveness Analysis
- a-Synuclein
- Oxidative Stress
- Neurodegeneration
- Parkinson's Disease
- Cardiovascular Outcomes
- Quality of Life
- Cost of Care
- Neurotransmission
- Amyloid Hypothesis
- Cetuximab
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Neurodegeneration142 topics
- Oxidative Stress142 topics
- Parkinson's Disease91 topic
- a-Synuclein91 topic
- Cardiovascular Outcomes71 topic
- Cost-effectiveness Analysis71 topic
- Quality of Life71 topic
- Type 2 Diabetes71 topic
- Cost of Care61 topic
- Financial Toxicity61 topic
- Neurotransmission61 topic
- Synaptic Plasticity61 topic
- Amyloid Hypothesis51 topic
- Biosimilars51 topic
- Cetuximab51 topic
- Immunogenicity51 topic
- KRAS Mutations51 topic
- Tau Pathology51 topic
Where does Paul L. Juneau work?
Paul L. Juneau's main affiliation in the publication record is Truven Health Analytics (United States), United States.
How many publications and citations does Paul L. Juneau have?
OpenAlex counts 91 works and 3,262 citations for Paul L. Juneau, an h-index of 25, ranking #1,888,092 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Paul L. Juneau
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul L. Juneau. Posts are plain text and can be reported.